Use of Telehealth by Surgical Specialties During the COVID-19 Pandemic.


Journal

JAMA surgery
ISSN: 2168-6262
Titre abrégé: JAMA Surg
Pays: United States
ID NLM: 101589553

Informations de publication

Date de publication:
01 07 2021
Historique:
pubmed: 27 3 2021
medline: 23 7 2021
entrez: 26 3 2021
Statut: ppublish

Résumé

While telehealth use in surgery has shown to be feasible, telehealth became a major modality of health care delivery during the COVID-19 pandemic. To assess patterns of telehealth use across surgical specialties before and during the COVID-19 pandemic. Insurance claims from a Michigan statewide commercial payer for new patient visits with a surgeon from 1 of 9 surgical specialties during one of the following periods: prior to the COVID-19 pandemic (period 1: January 5 to March 7, 2020), early pandemic (period 2: March 8 to June 6, 2020), and late pandemic (period 3: June 7 to September 5, 2020). Telehealth implementation owing to the COVID-19 pandemic in March 2020. (1) Conversion rate defined as the rate of weekly new patient telehealth visits divided by mean weekly number of total new patient visits in 2019. This outcome adjusts for a substantial decrease in outpatient care during the pandemic. (2) Weekly number of new patient telehealth visits divided by weekly number of total new patient visits. Among 4405 surgeons in the cohort, 2588 (58.8%) performed telehealth in any patient care context. Specifically for new patient visits, 1182 surgeons (26.8%) used telehealth. A total of 109 610 surgical new outpatient visits were identified during the pandemic. The median (interquartile range) age of telehealth patients was 46.8 (34.1-58.4) years compared with 52.6 (38.3-62.3) years for patients who received care in-person. Prior to March 2020, less than 1% (8 of 173 939) of new patient visits were conducted through telehealth. Telehealth use peaked in April 2020 (week 14) and facilitated 34.6% (479 of 1383) of all new patient visits during that week. The telehealth conversion rate peaked in April 2020 (week 15) and was equal to 8.2% of the 2019 mean weekly new patient visit volume. During period 2, a mean (SD) of 16.6% (12.0%) of all new patient surgical visits were conducted via telehealth (conversion rate of 5.1% of 2019 mean weekly new patient visit volumes). During period 3, 3.0% (2168 of 71 819) of all new patient surgical visits were conducted via telehealth (conversion rate of 2.5% of 2019 new patient visit volumes). Mean (SD) telehealth conversion rates varied by specialty with urology being the highest (14.3% [7.7%]). Results from this study showed that telehealth use grew across all surgical specialties in Michigan in response to the COVID-19 pandemic. While rates of telehealth use have declined as in-person care has resumed, telehealth use remains substantially higher across all surgical specialties than it was prior to the pandemic.

Identifiants

pubmed: 33769434
pii: 2778017
doi: 10.1001/jamasurg.2021.0979
pmc: PMC7998347
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

620-626

Subventions

Organisme : AHRQ HHS
ID : K08 HS027632
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Grace F Chao (GF)

National Clinician Scholars Program, University of Michigan, Ann Arbor.
Veterans Affairs Ann Arbor, Ann Arbor, Michigan.
Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

Kathleen Y Li (KY)

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.
Department of Emergency Medicine, University of Michigan, Ann Arbor.
Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Ziwei Zhu (Z)

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

Jeff McCullough (J)

Department of Health Management and Policy, University of Michigan, Ann Arbor.

Mike Thompson (M)

Department of Cardiac Surgery, Michigan Medicine, Ann Arbor.

Jake Claflin (J)

Department of Urology, University of Michigan, Ann Arbor.

Maximilian Fliegner (M)

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

Emma Steppe (E)

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

Andrew Ryan (A)

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

Chad Ellimoottil (C)

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.
Department of Urology, University of Michigan, Ann Arbor.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH